Alan A. Boulton
Affiliations: | University of Saskatchewan, Saskatoon, SK, Canada |
Area:
Neuroscience Biology, Molecular BiologyGoogle:
"Alan Boulton"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Waldmeier PC, Boulton AA, Cools AR, et al. (2000) Neurorescuing effects of the GAPDH ligand CGP 3466B Journal of Neural Transmission, Supplement. 197-214 |
| Li XM, Juorio AV, Qi J, et al. (1999) L-deprenyl induces aromatic L-amino acid decarboxylase (AADC) mRNA in the rat substantia nigra and ventral tegmentum: An in situ hybridization study Molecular and Chemical Neuropathology. 35: 149-155 |
| Zhang X, Zuo DM, Davis BA, et al. (1996) Immunohistochemical evidence of neuroprotection by R(-)-deprenyl and N-(2-hexyl)-N-methylpropargylamine on DSP-4-induced degeneration of rat brain noradrenergic axons and terminals. Journal of Neuroscience Research. 43: 482-9 |
| Paterson IA, Davis BA, Durden DA, et al. (1995) Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brain Neurochemical Research. 20: 1503-1510 |
| Yu PH, Davis BA, Zhang X, et al. (1995) Neurochemical, neuroprotective and neurorescue effects of aliphatic N-methylpropargylamines; new MAO-B inhibitors without amphetamine-like properties Progress in Brain Research. 106: 113-121 |
| Milgram NW, Ivy GO, Murphy MP, et al. (1995) Effects of chronic oral administration of L-deprenyl in the dog. Pharmacology, Biochemistry, and Behavior. 51: 421-8 |
| Yu PH, Davis BA, Boulton AA. (1995) Aliphatic propargylamines, a new series of potent selective, irreversible non-amphetamine-like MAO-B inhibitors: Their structures, function and pharmacological implications Advances in Experimental Medicine and Biology. 363: 17-23 |
| Fang J, Yu PH, Boulton AA, et al. (1995) Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia Psychopharmacology. 118: 206-212 |
| Yu PH, Davis BA, Durden DA, et al. (1994) Neurochemical and neuroprotective effects of some aliphatic propargylamines: New selective nonamphetamine-like monoamine oxidase B inhibitors Journal of Neurochemistry. 62: 697-704 |
| Yu PH, Davis BA, Fang J, et al. (1994) Neuroprotective effects of some monoamine oxidase-B inhibitors against DSP-4-induced noradrenaline depletion in the mouse hippocampus Journal of Neurochemistry. 63: 1820-1828 |